AOD-9604
Anti-Obesity Drug 9604
1815.1 Da
Liquid
~30 minutes
Refrigerate at 2–8°C, protect from light
// PAI-2026-05
AOD-9604
AOD-9604 is a modified fragment of human growth hormone (hGH) spanning amino acids 176–191. Unlike full hGH, it does not affect insulin levels or promote cell proliferation. Research focuses on its ability to stimulate lipolysis (fat breakdown), inhibit lipogenesis (fat formation), and support metabolic health. It is one of the most studied peptides for body composition and weight management.
Select Quantity
10 mg · Lyophilized
$207.19
per mg
$20.72
Mechanism of Action
- Stimulates lipolysis via β3-adrenergic receptor activation
- Inhibits lipogenesis without affecting IGF-1 levels
- Does not affect blood glucose or insulin sensitivity
- Mimics the fat-metabolizing action of hGH
Amino Acid Sequence
Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
Solubility
Liquid formulation — ready to use
Certificate of Analysis
Batch PAI-2026-05 · Issued Jul 26, 2026
99.5%
RP-HPLC · UV 220nm
Confirmed
LC-MS/MS · ESI+
<0.1 EU/mg
LAL method
<10 CFU/g
USP <61>
HPLC Purity Profile
99.5% main peak| Test | Method | Specification | Result | Status |
|---|---|---|---|---|
| Purity (HPLC) | RP-HPLC | ≥98.0% | 99.5% | PASS |
| Identity (MS) | LC-MS/MS | Conforms | Conforms | PASS |
| Appearance | Visual | White powder | Conforms | PASS |
| Moisture | Karl Fischer | ≤8.0% | 3.3% | PASS |
| Residual Solvents | GC-HS | ICH Q3C | Conforms | PASS |
| Endotoxins | LAL | <1 EU/mg | <0.1 EU/mg | PASS |
Testing performed by independent ISO-accredited laboratory. Full chromatograms and spectra available in the downloadable COA document.
Research References
AOD9604: an anti-obesity drug
Mol Cell Endocrinol · 2001
Safety and efficacy of AOD9604 in obese subjects
Obes Res · 2004
For research purposes only. These references are provided for informational use and do not constitute medical advice.
More in Weight Management
View all →Semaglutide
≥99.5% purity · 4113.6 Da
Long-acting GLP-1 receptor agonist studied for weight loss, blood sugar regulation, and cardiovascular protection.
Semaglutide / B12
≥99.5% purity · —
Semaglutide combined with Vitamin B12 to support energy metabolism and reduce common GLP-1 side effects.
Tirzepatide
≥99.5% purity · 4813.5 Da
Dual GIP/GLP-1 receptor agonist with superior weight loss outcomes vs. GLP-1 monotherapy. Up to 22% body weight reduction in trials.